
Research compound
PT-141
£36.00/ 10mg vial
Bremelanotide, cyclic melanocortin receptor agonist
PT-141 (bremelanotide) is a cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone and a metabolite of Melanotan II. It is an agonist at melanocortin receptors, with published activity at MC4R and MC3R, and is studied as a central-acting melanocortin probe rather than for pigmentation.
Supplied as a lyophilised powder in 10 mg vials, manufactured in the UK and independently tested batch by batch.
Research use centres on melanocortin receptor pharmacology and central signalling models. Laboratory research use only.
Order before 3pm for same-day UK dispatch on Royal Mail Tracked 24, from £4.99.
Independent testing
All lab reportsHPLC and mass spectrometry on every batch. Certificate of Analysis available on request.
Third-party analysis by Janoshik Analytical. Each certificate is verifiable on the laboratory’s own site.
- Manufactured and lyophilised in the UK
- Plain, tracked packaging from £4.99
- For laboratory research use only
Research Handling Guidance
Before reconstitution, allow both the lyophilised peptide and your chosen diluent to settle at normal laboratory room temperature. Equalising temperatures in this way supports the structural stability of the compound while it goes into solution.
Diluents and reconstitution solutions are purchased separately.